272 Addendum FDG-PET Fluorodeoxyglucose positron emission tomography FF Fresh frozen FFPE Formalin-fixed paraffin-embedded Fis1 Fission, mitochondrial 1 G Grade GAB1 GRB2-associated-binding protein 1 GPCR(s) G-protein-coupled receptor(s) GRB2 Growth factor receptor-bound protein 2 GRP(R) Gastrin-releasing peptide (receptor) Gr. Twrds. Gradient towards HE Hematoxylin and eosin HGF/SF Hepatocyte growth factor/scatter factor HNC(s) Head and neck cancer(s) HNSCC(s) Head and neck squamous cell carcinoma(s) HPV(-16) Human papillomavirus (type 16) HR(s) Hazard ratio(s) ICC(s) Intraclass correlation coefficient(s) IHC Immunohistochemistry KM Kaplan-Meier LPA Lysophosphatidic acid M Membranous MAPK Mitogen-activated protein kinase MET Hepatocyte growth factor/scatter factor receptor MET-CTF MET (membrane-anchored) COOH/C-terminal fragment MET-EC- Membrane-bound MET (fragment) lacking the ectodomain MET-ICD MET intracellular domain MET-NTF MET NH2/N-terminal fragment (mo)Ab(s) (Monoclonal) antibody(/ies) MPR Major pathological response MRI Magnetic resonance imaging N Nuclear NC(s) Negative control(s) NCCN National Comprehensive Cancer Network Neg. Negative NPV(s) Negative predictive value(s) N-term. N-terminal O(T)SCC(s) Oral (tongue) squamous cell carcinoma(s) OC(s) Oral cancer(s)/oral cavity cancer(s) OR(s) Odds ratio(s)
RkJQdWJsaXNoZXIy MTk4NDMw